Valcare Medical
valcaremedical.com
Cardiovascular Devices
Health Care
As featured in
Claim pageClaim
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
News
Transeptal Mitral Annuloplasty With the AMEND System: 6-Month Results of First in Man Cohort in Circulation: Cardiovascular Interventions
Transeptal Mitral Annuloplasty With the AMEND System: 6-Month Results of First in Man Cohort, by Drs. Melica, Carasso, Butnaru, Gogorishvili, Metreveli, Modine, Kurashvili, Farkash, Meerkin, has been accepted for publication in Circulation: Cardiovascular
Read more
Report
Valcare Medical Appoints Two New Members to Board of Directors
WILMINGTON, Del., March 6, 2026 /PRNewswire/ - Valcare Medical, Inc., a pioneer in transcatheter mitral valve repair solutions, today announced the appointment of two new members to its Board of Directors: Jeffrey B. Jump and Jacques Séguin, MD, PhD. Thes
Read more
Report
Valcare Medical Appoints Two New Members to Board of Directors
/PRNewswire/ -- Valcare Medical, Inc., a pioneer in transcatheter mitral valve repair solutions, today announced the appointment of two new members to its...
Read more
Report
Paul Sorajja, M.D. discusses the First-in-America Implantation of AMEND Annuloplasty Ring in Mitral Regurgitation
Listen to Dr. Paul Sorajja, Interventional Cardiologist at Banner University Medical Center Phoenix, describe the first implantation of the AMEND annuloplasty ring via a novel trans-septal system designed to help a leaky mitral valve. Video here: New cath
Read more
Report
How AMEND TMVr Annuloplasty System Is Re-engineering Mitral Valve Repair
Watch DeviceTalks host Tom Salemi interview Steve Sandweg CEO and Dr. David Meerkin CMO as they discuss how Valcare's AMEND TMVr Annuloplasty System is re-engineering mitral valve repair. Register here to gain immediate access to view the webinar recordin
Read more
Report
Valcare Medical Announces First U.S. Transseptal AMEND Implant in Early Feasibility Study
WILMINGTON, Del., February 11, 2026 /PRNewswire/ - Valcare Medical, Inc., a pioneer developer in transcatheter mitral valve repair solutions, today announced the successful first U.S. transseptal implantation of its AMEND Transcatheter Mitral Valve Repair
Read more
Report
Valcare Medical Announces First U.S. Transseptal AMEND Implant in Early Feasibility Study
/PRNewswire/ -- Valcare Medical, Inc., a pioneer developer in transcatheter mitral valve repair solutions, today announced the successful first U.S....
Read more
Report
Valcare Medical Receives FDA Approval to Initiate Early Feasibility Study for its Novel AMEND Trans-Septal System
HERZLIYA, Israel and WILMINGTON, Del., March 13, 2025 /PRNewswire/ - Valcare Medical Inc., a leading innovator in transcatheter-based mitral solutions, today announced the U.S. Food and Drug Administration (FDA) has approved the AMEND Trans-Septal System
Read more
Report
Valcare Medical Receives FDA Approval to Initiate Early Feasibility Study for its Novel AMEND Trans-Septal System
Valcare Medical Inc., a leading innovator in transcatheter-based mitral solutions, today announced the U.S. Food and Drug Administration (FDA) has approved the AMEND Trans-Septal System for investigational device exemption (IDE) application to commence an
Read more
Report
Show more news